Amcal and Guardian pharmacies are claiming the first six months of their national sleep apnoea program a success, based on program uptake and specialist referrals.
“The aim of the service is to provide customers with an accessible sleep apnoea assessment and help educate them on healthy sleep habits,” General Manager Amcal and Guardian Retail Brian Tomlin said.
Australian Pharmacy Sleep Services (APSS) is partnering with the two Sigma Healthcare brands providing pharmacist training and additional in-store pharmacy support. Mr Tomlin says this support has contributed greatly to the rollout of the sleep health program.
“With the assistance of APSS, approximately 175 stores nationwide now offer this industry-leading service, with an additional 25 set to offer the program in the coming months,” he said.
“Since August 2018, all sleep studies from the 175 stores who have undertaken the program have been assessed by Sleep Physician of Nepean Lung and Sleep, Dr Donald Lee who reports on behalf of APSS. The outcome of these assessments is discussed with the pharmacist with recommendations from Dr Lee.”
Amcal Senior Pharmacist James Nevile says assessment is critical in helping to educate Australians on the importance of healthy sleep.
“Millions are living with the condition without knowing it, so this service ensures high-quality support to those who need it most,” he said.
“Research suggests that four in 10 suffer from inadequate sleep, with half experiencing high levels of daytime sleepiness. The impact of this condition is far-reaching, with fatigue, daytime sleepiness and clumsiness all being typical symptoms.”
The tests can be completed overnight in the comfort of a patient’s own home. For more information, visit https://www.amcal.com.au/sleep-apnoea or visit your local Amcal pharmacy.
 Sleep Health Foundation, 2017